News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search


Pfizer New Zealand Response To The IMMP Assertions

Pfizer New Zealand Response To The IMMP Assertions.

Pfizer New Zealand today strongly disagrees with the statement issued by the IMMP, Pfizer General Manager Mark Crotty said.

“The assertions contained in the press release are incorrect, misleading and as such extremely irresponsible.”

“They go against the large body of data comparing cardiovascular risk between Celebrex and Vioxx,” he said.

“The ‘study’ referred to by the IMMP is a simply an adverse events monitoring system and does not take into account individual cardiovascular risk. It is not a clinical trial, and its results should be treated with extreme caution.”

“In additional, the IMMP data is not collected in a controlled fashion, and is dependent on the vigilant reporting of a medical practitioner,” stated Pfizer Australia and New Zealand Medical Director, Dr Bill Ketelbey.

“The statement from the IMMP that this is the first ‘study’ to compare cardiovascular risk of the two medicines is blatantly incorrect and misleading to the public.”

“The FDA in the United States recently published a ‘real life’ observational study designed to assess the cardiovascular risk of all NSAIDS (including Celebrex and Vioxx) and found there was no increased risk associated with Celebrex, whereas there was a significantly increased risk associated with Vioxx use. This study involved over 1.3 million people. In addition, three further independent studies (Ray et al; Solomon et al; Mamdani et al) involving over 570,000 patients have again illustrated an increased cardiovascular risk associated with Vioxx, and shown no increased risk with Celebrex. The results of these studies have been submitted to Medsafe as part of its review of the COX -2 class,” Dr Ketelbey said.

"The IMMP data involved only 11,000 people and, as admitted by the author, lacked the statistical power to detect a difference between these medicines that have repeatedly been shown to have different safety profiles. The inability of the IMMP data to detect a known difference between these two medicines merely adds support to the New Zealand government's decision to cease funding it." ENDS

© Scoop Media

Culture Headlines | Health Headlines | Education Headlines


Howard Davis: Review - A Girl Named Mo

Moana Ete brought her three-piece band A Girl Named Mo to Wellington's intimate and iconic Bats Theatre last week for a five-night residency. Each show was recorded and filmed live for the release of her debut album 'Platonic/Romantic' on Loop records later this year. More>>

For The Birds: Who Will Be Crowned Bird Of The Year?

The competition involves well-known and enthusiastic New Zealanders acting as ‘campaign managers’ for their favourite birds with many going to great lengths to get New Zealanders to vote for their chosen bird... More>>


  • Greening the Red Zone - Bird of the year heats up: kōtare concedes, backs kea
  • Image Out-Link - Giselle Clarkson on Twitter
  • Gordon Campbell: On Bob Dylan's Nobel (And The Surplus)

    So Bob Dylan has just won the Nobel Prize for… Literature? Wow. I’d be just as happy if he’d won for his work on particle physics (“One Grain of Sand”, “Simple Twist of Fate”) or got the Economics prize for his work on the theory of contracting (“Don’t Think Twice Its Alright”) ... More>>


    Scoop Review Of Books: Whose Goat Was That?

    Mysterious Mysteries of Aro Valley is a sharp, satirical and sometimes downright scary romp through and around that valley in ways that made me question the realities of the places I thought I knew so well. More>>


    NZ On Air TV Funding: More Comedy Comes Out Of The Shadows

    Paranormal Event Response Unit is a series conceived by Jemaine Clement and Taika Waititi as a TV spin-off from their highly acclaimed feature film What We Do In The Shadows. More>>


    Mars News: Winners Announced For The 2016 Apra Silver Scroll Awards

    Wellington singer-songwriter and internationally acclaimed musician Thomas Oliver has won the 2016 APRA Silver Scroll Award with his captivating love song ‘If I Move To Mars’. More>>


    Get More From Scoop



    Search Scoop  
    Powered by Vodafone
    NZ independent news